Ibrahim N - Search Results

1

Therapeutic breast cancer vaccines: a new strategy for early-stage disease.

Shumway NM, Ibrahim N, Ponniah S, Peoples GE, Murray JL. Shumway NM, et al. Among authors: ibrahim n. BioDrugs. 2009;23(5):277-87. doi: 10.2165/11313490-000000000-00000. BioDrugs. 2009. PMID: 19754218 Review.

2

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.

Ibrahim NK, Rahman Z, Valero V, Willey J, Theriault RL, Buzdar AU, Murray JL 3rd, Bast R, Hortobagyi GN. Ibrahim NK, et al. Cancer. 1999 Oct 1;86(7):1251-7. doi: 10.1002/(sici)1097-0142(19991001)86:7<1251::aid-cncr21>3.0.co;2-f. Cancer. 1999. PMID: 10506711 Clinical Trial.

3

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.

Hortobagyi GN, Ueno NT, Xia W, Zhang S, Wolf JK, Putnam JB, Weiden PL, Willey JS, Carey M, Branham DL, Payne JY, Tucker SD, Bartholomeusz C, Kilbourn RG, De Jager RL, Sneige N, Katz RL, Anklesaria P, Ibrahim NK, Murray JL, Theriault RL, Valero V, Gershenson DM, Bevers MW, Huang L, Lopez-Berestein G, Hung MC. Hortobagyi GN, et al. Among authors: ibrahim nk. J Clin Oncol. 2001 Jul 15;19(14):3422-33. doi: 10.1200/JCO.2001.19.14.3422. J Clin Oncol. 2001. PMID: 11454891 Clinical Trial.

4

Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation.

Ibrahim NK, Valero V, Rahman Z, Theriault RL, Walters RS, Buzdar AU, Booser DJ, Holmes FA, Murray JL 3rd, Willey J, Bast R, Hortobagyi GN. Ibrahim NK, et al. Cancer Invest. 2001;19(5):459-66. doi: 10.1081/cnv-100103844. Cancer Invest. 2001. PMID: 11458813 Clinical Trial.

5

Paclitaxel in the multimodality treatment for inflammatory breast carcinoma.

Cristofanilli M, Buzdar AU, Sneige N, Smith T, Wasaff B, Ibrahim N, Booser D, Rivera E, Murray JL, Valero V, Ueno N, Singletary ES, Hunt K, Strom E, McNeese M, Stelling C, Hortobagyi GN. Cristofanilli M, et al. Among authors: ibrahim n. Cancer. 2001 Oct 1;92(7):1775-82. doi: 10.1002/1097-0142(20011001)92:7<1775::aid-cncr1693>3.0.co;2-e. Cancer. 2001. PMID: 11745249 Clinical Trial.

6

Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.

Ibrahim NK, Rahman Z, Valero V, Murray JL 3rd, Frye D, Hortobagyi GN. Ibrahim NK, et al. Cancer Invest. 2002;20(1):29-37. doi: 10.1081/cnv-120000363. Cancer Invest. 2002. PMID: 11852999 Clinical Trial.

7

A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.

Giordano SH, Booser DJ, Murray JL, Ibrahim NK, Rahman ZU, Valero V, Theriault RL, Rosales MF, Rivera E, Frye D, Ewer M, Ordonez NG, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: ibrahim nk. Clin Cancer Res. 2002 Nov;8(11):3360-8. Clin Cancer Res. 2002. PMID: 12429622 Clinical Trial.

8

Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer.

Murray JL, Gillogly ME, Przepiorka D, Brewer H, Ibrahim NK, Booser DJ, Hortobagyi GN, Kudelka AP, Grabstein KH, Cheever MA, Ioannides CG. Murray JL, et al. Among authors: ibrahim nk. Clin Cancer Res. 2002 Nov;8(11):3407-18. Clin Cancer Res. 2002. PMID: 12429628

9

Clinical development of the STn-KLH vaccine (Theratope).

Ibrahim NK, Murray JL. Ibrahim NK, et al. Clin Breast Cancer. 2003 Feb;3 Suppl 4:S139-43. doi: 10.3816/cbc.2003.s.003. Clin Breast Cancer. 2003. PMID: 12620151 Review.

10

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer.

Trent JC, Valero V, Booser DJ, Esparza-Guerra LT, Ibrahim N, Rahman Z, Vernillet L, Patel S, David CL, Murray JL, Cristofanilli M, Hortobagyi GN. Trent JC, et al. Among authors: ibrahim n. Clin Cancer Res. 2003 Jul;9(7):2426-34. Clin Cancer Res. 2003. PMID: 12855614 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,838 results

Search Page